| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.8M | -17.1% |
| Cost of Revenue | $10.4M | -37.2% |
| R&D Expense | $22.5M | +126.6% |
| SG&A Expense | $35.1M | +102.7% |
| Operating Income | $42.7M | -52.1% |
| Interest Expense | $0 | — |
| Pre-tax Income | $44.1M | -50.6% |
| Income Tax | $10.2M | -48.5% |
| Net Income | $33.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.8M | -4.2% |
| Accounts Receivable | $45.4M | -45.7% |
| Inventory | $39.3M | +101.3% |
| Current Assets | $185.8M | -11.0% |
| Total Assets | $195.0M | -9.2% |
| Current Liabilities | $21.5M | -29.4% |
| Total Liabilities | $24.9M | -38.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $41.6M | +262.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | -$46.0M | -75.4% |
| Free Cash Flow | $41.6M | +263.6% |
| -51.2% |
| EPS (Basic) | $0.46 | -50.0% |
| EPS (Diluted) | $0.46 | -49.5% |
| Stockholders' Equity |
| $170.2M |
| -2.4% |